Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Functional Status of Patients with COPD Assessed by London Chest Activity of Daily Living Scale: Gender Association and Validity of a Cutoff Point.

Belo LF, Rodrigues A, Paes T, Machado FVC, Schneider LP, Vicentin AP, Probst VS, Pitta F, Hernandes NA.

Lung. 2019 Aug;197(4):509-516. doi: 10.1007/s00408-019-00235-2. Epub 2019 May 11.

PMID:
31079224
2.

Sedentary Behaviour and Physical Inactivity in Patients with Chronic Obstructive Pulmonary Disease: Two Sides of the Same Coin?

Schneider LP, Furlanetto KC, Rodrigues A, Lopes JR, Hernandes NA, Pitta F.

COPD. 2018 Oct;15(5):432-438. doi: 10.1080/15412555.2018.1548587.

PMID:
30822241
3.

Clinical impact of body composition phenotypes in patients with COPD: a retrospective analysis.

Machado FVC, Schneider LP, Fonseca J, Belo LF, Bonomo C, Morita AA, Furlanetto KC, Felcar JM, Rodrigues A, Franssen FME, Spruit MA, Pitta F, Hernandes NA.

Eur J Clin Nutr. 2019 Jan 14. doi: 10.1038/s41430-019-0390-4. [Epub ahead of print]

PMID:
30643222
4.

Difference Between Slow and Forced Vital Capacity and Its Relationship with Dynamic Hyperinflation in Patients with Chronic Obstructive Pulmonary Disease.

Martinez L, Rodrigues D, DonĂ¡ria L, Furlanetto KC, Machado FVC, Schneider LP, Ribeiro M, Hernandes NA, Pitta F.

Lung. 2019 Feb;197(1):9-13. doi: 10.1007/s00408-018-0174-y. Epub 2018 Oct 29.

PMID:
30374589
5.

Increasing Physical Activity in Daily Life in Chronic Obstructive Pulmonary Disease: To Solve the Puzzle, Every Piece Counts.

Rodrigues A, Schneider LP, Machado FVC, Brito IL, Pitta F.

Am J Respir Crit Care Med. 2018 Apr 15;197(8):1088-1089. doi: 10.1164/rccm.201710-2053LE. No abstract available.

PMID:
29206053
6.

Sedentary Behavior Is an Independent Predictor of Mortality in Subjects With COPD.

Furlanetto KC, DonĂ¡ria L, Schneider LP, Lopes JR, Ribeiro M, Fernandes KB, Hernandes NA, Pitta F.

Respir Care. 2017 May;62(5):579-587. doi: 10.4187/respcare.05306. Epub 2017 Mar 7.

7.

Intradermal application of vitamin D3 increases migration of CD14+ dermal dendritic cells and promotes the development of Foxp3+ regulatory T cells.

Bakdash G, Schneider LP, van Capel TM, Kapsenberg ML, Teunissen MB, de Jong EC.

Hum Vaccin Immunother. 2013 Feb;9(2):250-8. Epub 2013 Jan 4.

8.

Intradermally administered TLR4 agonist GLA-SE enhances the capacity of human skin DCs to activate T cells and promotes emigration of Langerhans cells.

Schneider LP, Schoonderwoerd AJ, Moutaftsi M, Howard RF, Reed SG, de Jong EC, Teunissen MB.

Vaccine. 2012 Jun 13;30(28):4216-24. doi: 10.1016/j.vaccine.2012.04.051. Epub 2012 Apr 25.

PMID:
22542815

Supplemental Content

Loading ...
Support Center